Glucagon-like pepetide-1 receptor agonist suggests novel therapeutic options for hypothalamic obesity.

• Tác giả: Xiaoping Chen, Wanlu Ma, Bo Zhang
• Ngôn ngữ: eng
• Ký hiệu phân loại: 951.24904 *Southeastern China and adjacent areas
• Thông tin xuất bản: Japan : Journal of diabetes investigation , 2025
• Bộ sưu tập: NCBI
• ID: 678153

Tóm tắt

We briefly summarizes the mechanism of GLP-1RA therapy in HO both in rodents and in humans. We also summarized the clinical trials and case reports of GLP-1RA therapy in HO, especially the more and more often used semaglutide. We are hoping the therapy of GLP-1RA in HO will arouse more attention from clinicians in the future.